Mr. Matthew C. Schroeder

Chief Financial Officer & Executive Vice President

Mr. Paul D. Gilbert

Executive Vice President, Gen. Counsel & Corporation Sec.

Mr. Steve  Bixler

Chief Accounting Officer

Ms. Elizabeth H. Burr

Interim Chief Executive Officer & Director

Byron  Purcell

Vice President of Investor Relations & Treasurer

Ms. Heyward Rutledge Donigan B.A.

Pres, Chief Executive Officer & Director

Mr. Justin L. Mennen

Executive Vice President and Chief Technology & Digital Officer

Mr. Frank G. Vitrano

Chief Strategic Bus. Devel. Officer

Mr. Christopher S. Hall

Senior Vice President of Pharmacy Services

Executive Vice President, Gen. Counsel, Chief Legal Officer & Corporation Sec.

Mr. Brian T. Hoover

Chief Accounting Officer & Senior Vice President

Joy Errico Seusing

Senior Vice President & Chief Communications Officer

Ms. Jessica  Kazmaier

Executive Vice President & Chief HR Officer

Mr. Scott  Bernard

Senior Vice President of Eastern Division

Mr. Daniel  Miller

Senior Vice President of Pharmacy Regulatory Affairs

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and general merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. In addition, this segment offers healthcare coaching and disease management services to health plans and employers. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. As of February 26, 2022, the company operated 2,450 retail pharmacy locations in 17 states. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

Top 5 Defensive Stocks That Are Set To Fly

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) will release financial results for its Fiscal 2023 Fourth Quarter, which ended March 4, 2023, on Thursday, April 20, 2023. The company will hold an analyst call at 8:30 a.m. ET with remarks by Rite Aid's management team. The call will be broadcast at https://investors.riteaid.com. The telephone replay will be available beginning at 12:00 p.m. ET on Thursday, April 20, 2023, through 11:59 p.m. ET on May 21, 2023.

Rite Aid to Release Fourth Quarter Results on April 20

Amazon has apparently added another retailer to its stable of home-delivery partners. The eCommerce giant has teamed up with pharmacy chain Rite Aid to offer two-hour delivery to Amazon Prime members in parts of Newark, N.J.

Rite Aid Teams With Amazon to Offer 2-Hour Delivery

The U.S. Justice Department said Rite Aid “dispensed controlled substances in violation of the False Claims Act and the Controlled Substances Act.”

A Costly DOJ Probe Could Thwart Rite Aid Turn Around

“These practices opened the floodgates for millions of opioid pills and other controlled substances to flow illegally out of Rite Aid's stores,” on DOJ official said.

US sues Rite Aid for repeated unlawful opioid prescriptions

DOJ Sues Rite Aid for Allegedly Filling Opioid Prescriptions With ‘Obvious Red Flags’ 

Rite Aid CEO Heyward Donigan Leaves

Rite Aid Stock Is Soaring. The Outlook Impresses Investors.

Rite Aid Stock Plummets. Why This Analyst Believes the Shares Could Fall to $1. 

Rite Aid Stock Soars After Upbeat Forecast. The Chain Is Shrinking. 

BlackBerry, Lucid, Nike: What to Watch When the Stock Market Opens Today

Powered by AI

Rite Aid Corporation

2.11